NEW YORK (360Dx) – Novacyt today reported a 35 percent increase in its full-year 2017 revenues amid higher sales of its Primerdesign PCR and Novaprep liquid cytology products.

Novacyt reported 2017 revenues of €15.0 million ($18.6 million), up from €11.1 million in 2016. At constant exchange rates (CER), the company's sales were up 43 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.